STAAR Surgical | STAA - Operating Profit


STAAR Surgical reported $18.49M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Bausch Health Companies USD 717M 260M Sep/2025
Boston Scientific USD 1.04B 98M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Exact Sciences USD -25M 22.85M Sep/2025
Hologic USD 237M 16M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Novartis USD 4.5B 363M Sep/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025